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Abstract
Objective To determine the accuracy with which a single progesterone
measurement in early pregnancy discriminates between viable and
non-viable pregnancy.
Design Systematic review and meta-analysis of diagnostic accuracy
studies.
Data sources Medline, Embase, CINAHL, Web of Science, ProQuest,
Conference Proceedings Citation Index, and the Cochrane Library from
inception until April 2012, plus reference lists of relevant studies.
Study selection Studies were selected on the basis of participants
(women with spontaneous pregnancy of less than 14 weeks of gestation);
test (single serum progesterone measurement); outcome (viable
intrauterine pregnancy, miscarriage, or ectopic pregnancy) diagnosed
on the basis of combinations of pregnancy test, ultrasound scan,
laparoscopy, and histological examination; design (cohort studies of test
accuracy); and sufficient data being reported.
Results 26 cohort studies, including 9436 pregnant women, were
included, consisting of 7 studies in women with symptoms and
inconclusive ultrasound assessment and 19 studies in women with
symptoms alone. Among women with symptoms and inconclusive
ultrasound assessments, the progesterone test (5 studies with 1998
participants and cut-off values from 3.2 to 6 ng/mL) predicted a non-viable
pregnancy with pooled sensitivity of 74.6% (95% confidence interval
50.6% to 89.4%), specificity of 98.4% (90.9% to 99.7%), positive
likelihood ratio of 45 (7.1 to 289), and negative likelihood ratio of 0.26
(0.12 to 0.57). The median prevalence of a non-viable pregnancy was
73.2%, and the probability of a non-viable pregnancy was raised to
99.2% if the progesterone was low. For women with symptoms alone,
the progesterone test had a higher specificity when a threshold of 10
ng/mL was used (9 studies with 4689 participants) and predicted a
non-viable pregnancy with pooled sensitivity of 66.5% (53.6% to 77.4%),
specificity of 96.3% (91.1% to 98.5%), positive likelihood ratio of 18 (7.2
to 45), and negative likelihood ratio of 0.35 (0.24 to 0.50). The probability
of a non-viable pregnancy was raised from 62.9% to 96.8%.
Conclusion A single progesterone measurement for women in early
pregnancy presenting with bleeding or pain and inconclusive ultrasound
assessments can rule out a viable pregnancy.
Introduction
Vaginal bleeding and abdominal pain are the most common
causes of consultation in early pregnancy; 30% of women will
experience pain or bleeding in their first trimester.1 These
symptoms lead to anxiety and can be the first signs of a possible
miscarriage or an ectopic pregnancy. Miscarriage occurs in
10-20% of all recognised pregnancies, and the prevalence of
ectopic pregnancies in the United Kingdom is 1.6%, which is
raised to 3% in women with symptoms.2-4Most women seeking
medical advice have a transvaginal ultrasound scan to confirm
a viable pregnancy, a miscarriage, or an ectopic pregnancy.
However, even with expert use of transvaginal ultrasound,
confirming if a pregnancy is intrauterine or extrauterine may
not be possible in 8-31% of cases at the first visit.5 An
observational study of pregnancies with inconclusive ultrasound
results has shown that 50% spontaneously resolve (decreasing
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concentrations of β human chorionic gonadotrophin (β-hCG)),
27% are subsequently diagnosed as viable, and 14% are
diagnosed as ectopic pregnancies.6 The high incidence of
miscarriages and ectopic pregnancies in women with
inconclusive ultrasound results warrants further tests to reach
a diagnosis. Measurement of serum β-hCG can be useful, but
often more than one β-hCG measurements is needed to make a
diagnosis.7
Serum progesterone has been proposed as a useful test to
distinguish a viable pregnancy from a miscarriage or ectopic
pregnancy.8 Low progesterone values are associated with
miscarriages and ectopic pregnancies, both considered
non-viable pregnancies, and high progesterone concentrations
with viable pregnancies.8 Knowledge about the diagnostic
accuracy of a single serum progesterone measurement to
determine the viability of the pregnancy may accelerate
diagnosis, avoiding further tests and unnecessary interventions,
and improve outcomes. National recommendations refrain from
defining how this test should be used in diagnostic algorithms.8
The reason for this is that clinical practice is informed by
individual small studies with unstable inferences and conflicting
results on the accuracy of a single serum progesterone
measurement in determining the viability of the pregnancy.5 6 8
A meta-analysis in 1998 did not take into account the recent
widespread use of transvaginal ultrasound, which may improve
the accuracy of this test.9 The aim of our review was to evaluate
the accuracy of a single progesterone measurement, by a
meta-analysis of diagnostic accuracy studies, to predict
pregnancy outcome in women with pain or bleeding in early
pregnancy with or without an inconclusive ultrasound diagnosis.
Methods
Literature search
We did a comprehensive literature search to identify studies
with a population of women with spontaneous pregnancy of
less than 14 weeks of gestation, in which the single serum
progesterone measurement was used to predict the outcome of
pregnancy (viable intrauterine pregnancy, miscarriage, or ectopic
pregnancy). The databases searched includedMedline, Embase,
CINAHL, and the Cochrane Library from inception to April
2012. We searched Medline, Embase and CINAHL by a
combination of the keywords for the test (progestor*) and
outcomes of interest (“ectopic pregnancy”, “tubal pregnancy”,
“viab* pregnancy”, “failing pregnancy”, “miscarr*”, and
“abort*”) with their associated medical subject and Emtree
headings.We searched the Cochrane Library with the keywords
“progesterone” and “pregnancy”. We placed no filters or
language restrictions to ensure maximal sensitivity of the
searches. We also checked the reference sections of all selected
articles for relevant papers.
Study selection
We selected the studies in two rounds: firstly, on title and
abstract, independently by two reviewers (IDG and MA);
secondly, on full text, also independently by two reviewers (JV
and NM), against pre-specified criteria. We selected studies that
assessed diagnostic accuracy or derived prediction rules. We
excluded case-control studies, narrative reviews, letters,
editorials, comments, and case series. We used systematic
reviews and meta-analyses only as a source of references.
Studies needed to include women with spontaneous early
pregnancy to be eligible for the review. We excluded studies
including women who had conceived after treatment to induce
ovulation, who had had progesterone supplementation or in
vitro fertilisation, as well as studies that included women above
a gestational age of 14 weeks. The index test was a single
measurement of serum progesterone. We excluded studies that
did not report a cut-off value for progesterone but reported
results only by high or low progesterone.
Data extraction and quality assessment
Two reviewers (JV and NM) extracted data, and a third reviewer
(IDG) checked the data. From the relevant articles, we extracted
information on study design, inclusion and exclusion criteria,
population (asymptomatic women/women with symptoms,
women with inconclusive transvaginal ultrasound results),
details of progesterone test (assay, cut-off value), details of other
tests (β-hCG, transvaginal ultrasound), details about pregnancy
outcomes (description, diagnostic methods), flow of patients,
and two by two tables for pregnancy outcomes according to
progesterone test. One reviewer (JV) assessed included studies
for methodological quality, and two reviewers (MA and NM)
checked them. We assessed the quality of studies by using an
outlined component approach for diagnostic accuracy studies
(QUADAS).10 The reference standard for our included studies
was the pregnancy outcome as defined during follow-up in the
original studies. For this reason, we omitted one item on the
time period from index test to reference standard, as the
reference standard diagnosis is normally reached within hours
or days virtually eliminating possible delayed verification bias
from all studies. We grouped studies according to whether
women presented with pain or bleeding and inconclusive
ultrasound examination or with symptoms alone.
Data synthesis and analysis
We plotted individual studies’ estimates of sensitivities and
specificities on summary receiver operating characteristics space
and forest plots for visual examination of heterogeneity. We
used the SAS statistical package to meta-analyse a pair of
sensitivity and specificity from each included study by using
the hierarchical summary receiver operating characteristics
approach.11 12 This approach estimates the position and shape
of the summary receiver operating characteristics curve and
takes into account both within and between study variations.
Many studies reported progesterone concentrations in ng/mL,
so we converted those in nmol/L to ng/mL. To generate a
summary receiver operating characteristics curve using all
available studies for each meta-analysis, where more than one
cut-off value was reported in a study we chose the two by two
table for the lowest cut-off value because lower cut-offs were
more widely reported in included studies. When all the
parameters of the hierarchical summary receiver operating
characteristics model could not be estimated owing to a limited
number of studies, we simplified it by assuming a symmetrical
shape for the curve. We considered methods that allow joint
synthesis of sensitivities and specificities at multiple thresholds,
but none was appropriate because most studies reported
sensitivity and specificity at a single threshold.13-15 For
meta-analysis of studies that used the same or similar cut-off
values, we used parameter estimates from the models to derive
summary operating points (that is, summary sensitivities and
specificities), with 95% confidence regions, and summary
likelihood ratios. We calculated post-test probabilities by using
the summary likelihood ratios and the median prevalence values
with their ranges as the pre-test probabilities.
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Results
Literature identification and study quality
Figure 1⇓ shows the literature search and study selection
process. We identified 4338 citations; we obtained 203 articles
for full text evaluation and identified another five studies
through manual checking of reference lists. We contacted 20
authors of 25 different studies for additional data. Five authors
replied to our emails, but only one of these authors could provide
us with additional information. Overall, 26 studies were eligible
for inclusion, with a total of 9436 participants. Nineteen studies
included women with pain or bleeding alone,16-33 and seven
studies included womenwith pain or bleeding and inconclusive
ultrasound diagnosis.34-40 The supplementary (web extra) table
shows the characteristics of the included studies.
Figure 2⇓ shows the results of the quality assessment. Most of
the studies of women with pain or bleeding with inconclusive
ultrasound examination were of high quality; all seven studies
included participants representative of the population of interest
and contained adequate details about the index and reference
standard tests. For pregnancies that resolved spontaneously,
two studies did not investigate further to differentiate between
a miscarriage and an ectopic pregnancy.34 35None of these seven
studies adopted blinding for the reference standard results. The
studies including women with pain or bleeding alone (without
ultrasound scan) were of intermediate quality, and potential
biases were difficult to exclude because of poor reporting of the
primary studies. Progesterone assays used in the primary studies
were found to be comparable and all were included. The
insufficient reporting along with the limited number of studies
prevented us from evaluating the effect of potential sources of
heterogeneity.
Progesterone test in women with pain or
bleeding and inconclusive ultrasound
Seven prospective cohort studies, including 2379 women, in
women with pain or bleeding and inconclusive ultrasound
diagnosis evaluated the diagnostic accuracy of the single serum
progesterone measurement to predict the possibility of a viable
pregnancy, miscarriage, or ectopic pregnancy. The thresholds
of progesterone used ranged from 3.2 to 11 ng/mL (10 to 35
nmol/L); the most commonly used threshold was 5 ng/mL (16
nmol/L), which was used in three studies.34 37 38 Figures 3⇓ and
4⇓ show the estimated sensitivities and specificities when using
the single progesterone measurement test for differentiating
between viable and non-viable pregnancies, which includes both
miscarriages and ectopic pregnancies. After meta-analysis of
five studies (1998 participants) with similar cut-off values (3.2
to 6 ng/mL),34-38 we found that a single progesterone
measurement predicted a non-viable pregnancy with pooled
sensitivity of 74.6% (95% confidence interval 50.6% to 89.4%),
specificity of 98.4% (90.9% to 99.7%), positive likelihood ratio
of 45 (7.1 to 289), and negative likelihood ratio of 0.26 (0.12
to 0.57). In the studies included in this meta-analysis, the median
prevalence of a non-viable pregnancy was 73.2%. However, if
progesterone was lower than the cut-off value (3.2 to 6 ng/mL),
the probability of a non-viable pregnancy was 99.2% compared
with 44.8% if progesterone was higher. The progesterone test
had a very poor predictive accuracy for diagnosing ectopic
pregnancy, for which a low progesterone concentration did not
rule in or out an ectopic pregnancy (table⇓).
Progesterone test in women with pain or
bleeding alone
Nineteen cohort studies, including 7057 women, evaluated the
diagnostic accuracy of the single serum progesterone
measurement to predict pregnancy outcomes in women with
pain or bleeding alone. The table⇓ shows the pooled diagnostic
accuracy estimates for identifying women with non-viable
pregnancies with the most commonly reported thresholds, and
figure 5⇓ shows the estimates separately for each study
according to available cut-off values. For womenwith symptoms
alone, the progesterone test had a higher specificity using a
threshold of 10 ng/mL (nine studies with 4689
participants18 20 21 24 26 29-32), rather than higher thresholds at 15
and 20 ng/mL, and predicted a non-viable pregnancywith pooled
sensitivity of 66.5% (53.6% to 77.4%), specificity of 96.3%
(91.1% to 98.5%), positive likelihood ratio of 18 (7.2 to 45),
and negative likelihood ratio of 0.35 (0.24 to 0.50). The median
prevalence of a non-viable pregnancy in the studies included in
this analysis was 62.9%; this was raised to 96.8% if the
progesterone was lower than 10 ng/mL compared with a 37.2%
probability if the progesterone was higher.
Figure 6⇓ shows summary receiver operating characteristics
curves for commonly reported cut-off values and a curve of all
studies at a selected threshold for each study. This shows that
for higher thresholds the specificity is lower with generally
higher sensitivity. Specifically, with a threshold of 15 ng/mL
(nine studies with 5128 participants20 22-25 27 28 31 32) this test
predicted a non-viable pregnancy with pooled sensitivity of
83.3% (66.6% to 92.6%), specificity of 87.5% (78.5% to 93.1%),
positive likelihood ratio of 6.7 (3.8 to 12), and negative
likelihood ratio of 0.35 (0.09 to 0.5); with a threshold of 20
ng/mL (eight studies with 4348 participants17 20 21 23 24 26 29 31) it
predicted a non-viable pregnancy with pooled sensitivity of
85.7% (72.3% to 93.2%), specificity of 66.6% (47% to 91.8%),
positive likelihood ratio of 2.6 (1.5 to 4.5), and negative
likelihood ratio of 0.22 (0.1 to 0.47).
In the McCord 1996 study,24 2248 of 3674 participants had
non-viable pregnancies. This constitutes 78% of the number of
participants with non-viable pregnancies in the analyses at 10
and 15 ng/mL cut-off values and 84% of the non-viable
pregnancies in the analysis at 20 ng/mL. In a sensitivity analysis,
the effect of removal of the study on the summary estimates at
each cut-off value was negligible.
Discussion
Themeta-analysis shows that a single progesteronemeasurement
is useful in predicting non-viable pregnancies in women with
pain or bleeding when an ultrasound investigation proves to be
inconclusive. A low concentration of progesterone (less than
3.2 to 6 ng/mL) in these women ruled out a viable pregnancy
in 99.2% ofwomen. However, the test cannot distinguishwomen
with an ectopic pregnancy from those with an early normal
pregnancy or a miscarriage and should not be used for this
purpose. For women with symptoms but without an ultrasound
investigation, it may also be a useful test but is less accurate for
ruling out women with a normal viable pregnancy.
Strengths and weaknesses of study
The strengths of our study are that we did an extensive
systematic search of electronic databases without language
restrictions, which would have captured all existing good quality
studies. The high number of included studies in our
meta-analyses strengthens the power of our conclusions and
enabled us to explore the diagnostic accuracy of the progesterone
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test for multiple cut-off values. The methodological quality of
the studies included in the review was satisfactory, but some
limitations of doing pragmatic studies in this clinical setting
were highlighted. The classification of women according to
their pregnancy outcome, which was used as the reference
standard, is a problem for miscarriages and ectopic pregnancies
as in many cases a firm diagnosis cannot be made. Even though
the studies did not adopt a blinded assessment of the reference
standard, which in our case was the final diagnosis, this is
unlikely to have introduced bias when it comes to distinguishing
between viable and non-viable pregnancies, as viable
pregnancies lead to a live birth and most of the studies had long
enough follow-up to verify this outcome. The primary studies
did not adjust for known confounding factors, such as the
gestational age, but this could be explained by the high
prevalence of non-viable pregnancies, in which changes in
progesterone concentrations are poorly described compared
with viable pregnancies.41 Assessment of quality was also
hampered by unclear reporting in some studies. Poor reporting
occurred in most of the studies in the description of the reference
standard, reporting of uninterpretable results, and explanation
of withdrawals from the study.
Many studies, especially for women with pain or bleeding who
did not have an ultrasound assessment, had very different
prevalences of pregnancy outcomes compared with more recent
studies; this reflects the different clinical settings and
populations that this test evaluated. Despite the heterogeneity,
all studies reported good predictive ability of the progesterone
test to differentiate viable pregnancies from miscarriages and
ectopic pregnancies, especially in women with pain or bleeding
with inconclusive ultrasound results, in whom the chance of
miscarriages or ectopic pregnancies is high. The test, therefore,
has generalisability and may be applicable in clinical practice
in a variety of settings.
Strengths andweaknesses in relation to other
studies
The Royal College of Obstetricians and Gynaecologists’
guideline for early pregnancy suggests that the single serum
progesterone measurement is a useful test to predict pregnancy
outcome.8 It states that a threshold for serum progesterone of
20 nmol/L (about 6.2 ng/mL) has a sensitivity of 93% and
specificity of 94% to predict a non-viable pregnancy in women
with symptoms and inconclusive ultrasound but acknowledges
that no discriminatory value for this test exists to confidently
rule in or out a normal viable pregnancy. This conflicts with
the findings in this meta-analysis, which is based also on the
studies cited by this guideline.24 34 39 The existing evidence shows
that specificity is higher (98.4%) and sensitivity lower (74.6%)
using a cut-off value around 5 ng/mL. The findings of our study
support those of a meta-analysis by Mol et al in 1998,9 which
focused on a single progesteronemeasurement to predict ectopic
pregnancy. The results of that study showed that a single
progesteronemeasurement was useful for predicting the viability
of a pregnancy but not for discriminating between an ectopic
and a non-ectopic pregnancy, and this agrees with our results.
The clinically most relevant question of accuracy of
progesterone in women with inconclusive ultrasound
investigations, however, is not covered by Mol et al.
Meaning of study: implications for clinicians
The outcome of a pregnancy in women with pain or bleeding
in early pregnancy cannot be determined clinically alone after
inconclusive ultrasound assessments. In such situations, a chance
exists of a normal viable pregnancy that may be too early to be
detected on ultrasound; our review estimates the median
prevalence of this to be 26.8%. Most women, however, have a
non-viable pregnancy in the form of a miscarriage or an ectopic
pregnancy. Serial serum β-hCG measurements are needed to
differentiate between these outcomes in most diagnostic
algorithms.7 Suboptimal rise in β-hCG (<66%) after 48 hours
indicates that miscarriage or ectopic pregnancy is a possibility.
However, a rise in suboptimal β-hCGmay occur even in viable
pregnancies in up to 19% of cases.7 Therefore, the β-hCG test
should be complemented by another test to increase its
diagnostic accuracy. Serum progesterone measurement is a
non-invasive test that can be done at the same time that blood
is drawn for β-hCG measurements. It is already in use in many
early pregnancy assessment units, although the accuracy of the
progesterone test and the interpretation of the measured
concentrations are uncertain. This test could be added to the
existing algorithms for evaluation of early pregnancy, and its
effect should be evaluated through a randomised trial comparing
algorithms with and without serum progesterone.42 Our review
suggests that a single serum progesterone measurement is more
accurate when it follows an inconclusive ultrasound assessment;
in women with pain or bleeding who did not have an ultrasound
scan, the progesterone test was less accurate in predicting
viability of a pregnancy.
In conclusion, this meta-analysis found that a single
progesterone measurement for women in early pregnancy
presenting with bleeding or pain and inconclusive ultrasound
assessments can rule out a viable pregnancy.
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Table
Table 1| Summary estimates for each pregnancy outcome at different thresholds in women with pain and/or bleeding with inconclusive
ultrasound diagnosis and for women with pain and/or bleeding alone















negative (%)After test if positive (%)
Before test
(%)
Women with pain and/or bleeding with inconclusive ultrasound diagnosis
Progesterone test to predict ectopic v non-ectopic pregnancy:










Progesterone test to predict non-viable v viable pregnancy:










Women with pain and/or bleeding alone
Progesterone test to predict non-viable v viable pregnancy:
37.2 (24-47.1)96.8 (94.2-97.9)62.9 (47.4-71.8)0.35 (0.24 to
0.50)


























*Pre-test probabilities are median prevalence values with corresponding ranges.
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Figures
Fig 1 Flow chart of study selection. *Three studies by Stovall et al reported same patients as study by McCord et al. Study
by McCord was included, because it reported on more participants
Fig 2 Cumulative bar plot of methodological quality items across studies including women with pain or bleeding and
inconclusive ultrasound (top) and women with pain or bleeding alone (bottom)
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Fig 3 Forest plot of study results of progesterone test in women with pain or bleeding and inconclusive ultrasound assessment
grouped according to outcome. FN=false negative; FP=false positive; TN=true negative; TP=true positive
Fig 4 Summary receiver operating characteristics plot of progesterone test at cut-off values between 3.2 and 6.4 ng/mL
used to identify non-viable pregnancies in women with pain or bleeding and inconclusive ultrasound assessment (black
dot=summary sensitivity and specificity; dotted region around it=95% confidence region)
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Fig 5 Forest plot of study results of progesterone test at various cut-off values used to identify non-viable pregnancies in
women with pain or bleeding alone. Study names with suffixes A to D reported accuracy of progesterone at more than one
cut-off. FN=false negative; FP=false positive; TN=true negative; TP=true positive
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Fig 6 Summary receiver operating characteristics plot of progesterone test at different cut-off values used to identify
non-viable pregnancies in women with pain or bleeding alone
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